SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-064843
Filing Date
2023-05-25
Accepted
2023-05-25 20:39:52
Documents
1
Period of Report
2023-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317083-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2317083-6_4seq1.xml 4 6078
  Complete submission text file 0001104659-23-064843.txt   7538
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENEXTRA S.P.A., VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address
Fundaro Paolo (Reporting) CIK: 0001559537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 23962726